Division of Hematology and Oncology, Department of Pediatrics, Washington University, School of Medicine, St. Louis, Missouri; Department of Pediatrics and Communicable Diseases, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan.
Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.
Am J Prev Med. 2019 Jan;56(1):74-83. doi: 10.1016/j.amepre.2018.07.038.
Human papillomavirus (HPV) vaccine coverage in the U.S. is persistently suboptimal, despite research describing barriers to vaccination and strategies to increase vaccination coverage. The objective was to assess providers' approach to the HPV vaccine and their implementation of strategies to increase HPV vaccination coverage. The hypothesis was that adoption of improvement measures to address underuse of the HPV vaccine has not occurred.
Community pediatric providers from two Midwestern practice-based research networks completed self-administered electronic surveys. Data were collected over 6 months in 2015 and organized and analyzed in 2016.
There were 100 providers that participated. Despite agreement with national recommendations, some providers delayed their recommendation until the adolescent was older and many reported missed vaccination opportunities. Many providers experienced parental concerns including safety of the HPV vaccine, belief their child was not at risk of HPV infection, and their child's resistance to receiving multiple shots. Providers identified the following as barriers to adherence to Advisory Committee on Immunization Practices guidelines: bad publicity of the HPV vaccine, information about the HPV vaccine on the web, and a lack of a follow-up system for those who delayed HPV vaccine initiation. Approximately half of the participants had implemented strategies to address these barriers beyond offering immunization-only appointments.
Participants were aware of barriers to HPV vaccine use, but many had not adopted a systematic approach to increase vaccine coverage. A better understanding of the challenges facing providers to adopting improvement measures and a strategy to address barriers to implementation are needed to improve HPV coverage.
尽管研究描述了接种疫苗的障碍和增加疫苗接种覆盖率的策略,但美国的人乳头瘤病毒(HPV)疫苗接种率仍然持续不理想。目的是评估提供者对 HPV 疫苗的处理方法以及他们实施增加 HPV 疫苗接种覆盖率的策略。假设是,尚未采取改善措施来解决 HPV 疫苗使用不足的问题。
来自两个中西部基于实践的研究网络的社区儿科提供者完成了自我管理的电子调查。数据于 2015 年在 6 个月内收集,并于 2016 年进行组织和分析。
有 100 名参与者。尽管同意国家建议,但一些提供者将其推荐推迟到青少年年龄较大时,许多人报告错过了接种机会。许多提供者都遇到了父母的担忧,包括 HPV 疫苗的安全性、认为他们的孩子没有感染 HPV 的风险,以及他们的孩子对接受多次注射的抵制。提供者认为以下是遵守免疫实践咨询委员会指南的障碍:HPV 疫苗的负面宣传、网络上有关 HPV 疫苗的信息,以及缺乏针对那些推迟 HPV 疫苗接种启动的后续系统。大约一半的参与者已经实施了策略来解决这些障碍,而不仅仅是提供免疫接种预约。
参与者意识到 HPV 疫苗使用的障碍,但许多人尚未采取系统方法来提高疫苗覆盖率。需要更好地了解提供者在采用改进措施方面面临的挑战,以及解决实施障碍的策略,以提高 HPV 覆盖率。